MR ASAP Trial organization

MR ASAP will be conducted by members of the CONTRAST consortium.

The MR ASAP project is led by:

H. Bart van der Worp, MD PhD
Chief Investigator MR ASAP
Department of Neurology and Neurosurgery
University Medical Center Utrecht (Sponsor)

Paul J. Nederkoorn, MD PhD
Co-Chief Investigator MR ASAP
Department of Neurology
Academic Medical Center

For contact information, see CONTACT.

Trial organization
The MR ASAP trial will be conducted in a maximum of 10 ambulance regions in the Netherlands. Below, you will find the participating centers per ambulance region.

Ambulance region	Center	City	Local Investigator
Amsterdam	Ambulance Amsterdam	Amsterdam	A. Siegers, MD
	Amsterdam UMC – location VUmc	Amsterdam	M.C. Visser, MD PhD
	Amsterdam UMC – location AMC	Amsterdam	P.J. Nederkoorn, MD PhD
	OLVG Hospital	Amsterdam	V.I.H. Kwa, MD PhD
	Waterland Hospital	Purmerend	C.P. Zwetsloot, MD PhD
Utrecht	Regional Ambulance Organisation Utrecht	Utrecht	R.A. Boomars, MPA
	University Medical Center Utrecht	Utrecht	H.B. van der Worp, MD PhD
	Sint Antonius Hospital	Nieuwegein	W.J. Schonewille, MD PhD
	Diakonessen Hospital	Utrecht	R.C.J.M. Donders, MD PhD
	Meander Medical Center	Amersfoort	T.W.M. Raaijmakers, MD PhD
Zwolle	Regional Ambulance Organisation IJsselland	Zwolle	K. Caminada, MD
	Isala Hospital	Zwolle	P.S.S. Fransen, MD PhD
	Deventerziekenhuis	Deventer	M.H. Schipper, MD
Arnhem	Ambulance Gelderland-Midden	Arnhem	A. Gerritsen, MPA
	Rijnstate Hospital	Arnhem	J. Hofmeijer, MD PhD
	Hospital Gelderse Vallei	Ede	I. Miedema, MD PhD
	Slingeland Hospital	Doetinchem	J.A. van Vliet, MD PhD
Papendrecht	Zuid-Holland Zuid	Papendrecht	L. Esteve Cuevas, MD
	Albert Schweitzer Hospital	Dordrecht	H. Kerkhoff, MD PhD
	Beatrix Hospital	Gorinchem	R. van Eijkelenburg, MD PhD
Nijmegen	Gelderland-Zuid	Nijmegen	P. van Grinsven, MD PhD
	Radboud UMC	Nijmegen	F-E. de Leeuw, MD PhD
	Rivierenland Hospital	Tiel	J. Boomsma, MD PhD
	Canisius Wilhelmina Hospital	Nijmegen	G. van Dijk MD PhD

More participating centers will be added during the course of this trial.